When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Tocilizumab - Wikipedia

   en.wikipedia.org/wiki/Tocilizumab

   Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome, COVID‑19, and systemic sclerosis-associated interstitial lung disease (SSc-ILD).

3. FDA Approves ACTEMRA® for Children Living with a Rare Form of ...

   www.aol.com/2013/04/30/fda-approves-actemra-for...

   For premium support please call: 800-290-4726 more ways to reach us

4. Disease-modifying antirheumatic drug - Wikipedia

   en.wikipedia.org/wiki/Disease-modifying_anti...

   Although the use of the term DMARDs was first propagated in rheumatoid arthritis (hence their name), the term has come to pertain to many other diseases, such as Crohn's disease, lupus erythematosus, Sjögren syndrome, immune thrombocytopenic purpura, myasthenia gravis, sarcoidosis, and various others. [citation needed]

5. FDA Approves Expanded Indication for ACTEMRA® in ... - AOL

   www.aol.com/news/2012-10-12-fda-approves...

   FDA Approves Expanded Indication for ACTEMRA ® in Rheumatoid Arthritis SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY ...

6. LifeArc - Wikipedia

   en.wikipedia.org/wiki/LifeArc

   Four of these, Tysabri (Biogen Idec/Elan), Actemra (Hoffmann-La Roche/Chugai), Entyvio (Millenium Pharma/Takeda) and Keytruda (Merck/MSD), are licensed drugs. [ 4 ] In 2010, LifeArc signed a deal with the drug company AstraZeneca to share chemical compounds to help identify potential treatments for serious diseases.

7. FDA Approves ACTEMRA® for Children Living with a Rare Form of ...

   www.aol.com/news/2013-04-30-fda-approves-actemra...

   For premium support please call: 800-290-4726 more ways to reach us more ways to reach us

8. Adalimumab - Wikipedia

   en.wikipedia.org/wiki/Adalimumab

   Adalimumab, sold under the brand name Humira and others, is a disease-modifying antirheumatic drug and monoclonal antibody used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.

9. Genentech - Wikipedia

   en.wikipedia.org/wiki/Genentech

   2013: Gazyva (obinutuzumab): For use in combination with chlorambucil to treat patients with previously untreated chronic lymphocytic leukemia (CLL). Gazyva is the first drug with breakthrough therapy designation to receive FDA approval. 2014: Esbriet (pirfenidone): An anti-fibrotic drug for the treatment of idiopathic pulmonary fibrosis (IPF ...